Amyris To Present At The Evercore ISI 4th Annual HealthCONx Conference On December 1, 2021

Amyris, a leader in synthetic biotechnology, will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on December 1, 2021, at 3:30 pm ET.

Rhea-AI Summary

Amyris, a leader in synthetic biotechnology, will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on December 1, 2021, at 3:30 pm ET. This event aims to showcase Amyris's innovations in sustainable consumption through its Lab-to-Market™ platform, which combines advanced technology with biotechnology. Interested parties can access a live webcast and replay on the company's Investor Relations page.

Argus Session date unavailable

+4.83% session move Open Argus

Details

News Market Reaction – AMRS

The recorded move for AMRS in the trading session of this news was +4.83%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EMERYVILLE, Calif., Nov. 23, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, today announced that management will participate in a fireside chat at the Evercore ISI 4^th Annual HealthCONx Conference on Wednesday, December 1^st at 3:30 pm ET.

A live webcast of the presentation and a replay will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.

About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ operating platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products.

Amyris, the Amyris logo and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-to-present-at-the-evercore-isi-4th-annual-healthconx-conference-on-december-1-2021-301431144.html

SOURCE Amyris, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date and time of Amyris's presentation at the HealthCONx Conference?

Amyris will present at the Evercore ISI 4th Annual HealthCONx Conference on December 1, 2021, at 3:30 pm ET.

How can I watch the Amyris presentation live?

You can watch the live webcast of the Amyris presentation at the Evercore ISI HealthCONx Conference on their Investor Relations website.

What is Amyris known for in the biotechnology industry?

Amyris is known for its synthetic biotechnology innovations, particularly in creating sustainable ingredients for the Clean Health & Beauty and Flavors & Fragrances markets.

How does Amyris's Lab-to-Market platform work?

Amyris's Lab-to-Market platform integrates machine learning, robotics, and artificial intelligence to rapidly bring new sustainable products to market.

How many consumers use Amyris products?

Amyris ingredients are included in over 20,000 products, reaching more than 300 million consumers globally.